NASDAQ: GHRS - GH Research PLC

六个月盈利: -40.22%
部门: Healthcare

促销时间表 GH Research PLC

先进的时间表 简单图表
Financial Markets by TradingView

关于公司

GH Research PLC, a clinical-stage biopharmaceutical company, engages in developing various therapies to treat psychiatric and neurological disorders. The company develops 5-Methoxy-N,N-Dimethyltryptamine (5-MeO-DMT) therapies for the treatment of patients with treatment-resistant depression (TRD). Its lead program is GH001, an inhalable mebufotenin product candidate that has completed two Phase 1 clinical trials and Phase 1/2 clinical trial in patients with TRD.

更多详情
The company also develops GH002, an intravenous mebufotenin product candidate; and GH003, an intranasal mebufotenin product candidate, which are in preclinical development trials with a focus on psychiatric and neurological disorders. GH Research PLC was incorporated in 2018 and is based in Dublin, Ireland.
添加到比较列表
添加到观察列表
添加到投资组合
添加价格通知

EBITDA -0.00031
EV/EBITDA 1.61
IPO date 2021-06-25
ISIN IE000GID8VI0
Industry Biotechnology
P/BV 4.38
Sector Health Care
Валюта usd
Валюта отчета usd
Сайт https://www.ghres.com
Цена ао 11.09
Число акций ао 0.05202 млрд
每日价格变化: -2.47% (7.3)
每周价格变化: +3.94% (6.85)
每月价格变化: -23.28% (9.28)
3个月内价格变化: +3.49% (6.88)
六个月内的价格变化: -40.22% (11.91)
每年价格变化: +22.76% (5.8)
3年内价格变化: -70.78% (24.37)
5年内价格变化: 0% (7.12)
10年价格变化: 0% (7.12)
年初以来价格变化: +0.4231% (7.09)
所有参数

低估

姓名 意义 年级
P/S 0 0
P/BV 1.3 9
P/E 0 0
EV/EBITDA -5.09 0
全部的: 3.38

效率

姓名 意义 年级
ROA, % -15.73 0
ROE, % -16.25 0
全部的: 0

股息

姓名 意义 年级
Div yield, % 0 0
DSI 0 0
全部的: 0

责任

姓名 意义 年级
Debt/EBITDA -0.0084 10
全部的: 9.4

成长冲动

姓名 意义 年级
盈利能力 Revenue, % 0 0
盈利能力 Ebitda, % 13175.16 10
盈利能力 EPS, % 6062.78 10
全部的: 8
更多详情

机构 体积 分享, %
BVF Inc. 10400158 19.99
RA Capital Management, L.P. 5587333 10.74
RTW Investments LP 3327129 6.39
FMR, LLC 3136869 6.03
Lynx1 Capital Management Lp 1838617 3.53
VR Adviser, LLC 1318327 2.53
Verition Fund Management, LLC 1162485 2.23
Cormorant Asset Management, LP 593043 1.14
Deep Track Capital, LP 499400 0.96
5AM Venture Management, LLC 404404 0.78

ETF 分享, % 本年盈利能力, % 股息, %
AdvisorShares Psychedelics ETF 4.2406 845.99 0.20
SPDR S&P International Small Cap ETF 0.01104 8.94 3.10348



导师 职称 支付 出生年份
Mr. Florian Schonharting M.Sc. (Econ) Co-Founder & Non-Executive Chairman of the Board N/A 1969 (56 年)
Mr. Magnus Halle Co-Founder & MD of Ireland N/A 1997 (28 年)
Ms. Julie Ryan F.C.A. Vice President of Finance N/A 1986 (39 年)
Mr. Aaron Cameron M.B.A. Chief Operating Officer N/A 1985 (40 年)
Dr. Velichka Valcheva M.D. Chief Executive Officer N/A 1975 (50 年)

地址: Ireland, Dublin D RY, Joshua Dawson House - 在 Google 地图中打开, 打开 Yandex 地图
网站: https://www.ghres.com